Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Inf2 (inverted formin, FH2 and WH2 domain containing) Rattus norvegicus
Symbol: Inf2
Name: inverted formin, FH2 and WH2 domain containing
Description: Predicted to be involved in regulation of cellular component size and regulation of mitochondrial fission. Predicted to localize to the perinuclear region of cytoplasm. Human ortholog(s) of this gene implicated in Charcot-Marie-Tooth disease dominant intermediate E and focal segmental glomerulosclerosis 5. Orthologous to human INF2 (inverted formin, FH2 and WH2 domain containing); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; 1-naphthyl isothiocyanate; bisphenol A.
Type: protein-coding
RefSeq Status: MODEL
Also known as: inverted formin-2; LOC362790; LOW QUALITY PROTEIN: inverted formin-2; RGD1308350; similar to hypothetical protein MGC13251
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Rat AssemblyChrPosition (strand)SourceGenome Browsers
Rnor_6.06137,162,593 - 137,180,198 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.06146,170,182 - 146,187,667 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.16137,437,320 - 137,637,548 (+)NCBI
Celera6129,206,114 - 129,210,267 (+)NCBICelera
Celera6129,210,433 - 129,223,633 (+)NCBICelera
Cytogenetic Map6q32NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated


Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)


Nucleotide Sequences
Protein Sequences

Strain Variation

Strain Sequence Variants (Rnor 6.0)

Additional Information

External Database Links
Nomenclature History
More on Inf2
Alliance Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1308350
Created: 2005-01-12
Species: Rattus norvegicus
Last Modified: 2019-08-20
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.